Cobb County has filed a lawsuit accusing several major insulin manufacturers and pharmacy benefit managers (PBMs) of ...

After hitting a regulatory roadblock in 2022, Sanofi’s consumer healthcare business Opella has secured the FDA’s blessing to ...

The lawsuit said an “unfair and deceptive conspiracy” by drug makers and drug distributors fixed prices for Georgians.

28 days Prescribing information Insulin glargine (rDNA origin) vial or cartridge Lantus vial or cartridge (Sanofi-Aventis) 28 days Prescribing information 70% insulin aspart protamine suspension ...

Sanofi has formed another partnership to support its vision of insulin-based therapies that are connected with glucose monitoring devices and make it easier for patients to manage their blood ...

Columbus City Attorney Zach Klein announced that the city has filed a lawsuit against several drug companies and pharmacy ...

Eli Lilly’s big-selling insulin, Humalog, faces cut-price competition after the US regulator approved a biosimilar from Sanofi. Sanofi’s Admelog (insulin lispro) is approved in type 1 and type ...

Sanofi (SNY) intends to spend about $1.05B building a new insulin manufacturing base in China, Kimberley Kao of The Wall Street Journal reports. The company said the investment will enhance the ...

Pharmaceutical giant Sanofi has capped the price of its insulin, becoming the last of three major manufacturers of the drug to curb soaring costs of the lifesaving medication in the US.

This disposable insulin pen is to be used for the treatment ... the name of the parent company was changed globally from sanofi-aventis to Sanofi in May 2011.On 9 October 2012, Sanofi India ...

Sanofi–Aventis has signed an agreement with CureDM ... a fundamental problem is the loss of functional islet β-cell mass, resulting in insulin deficiency and hyperglycaemia,” explains ...